Successful treatment of refractory mevalonate kinase deficiency with combination therapy targeting TNFα and IL1β

Affiliations

• ¹ Faculty of Medecine, Université catholique de Louvain, Brussels, Belgium.
• ² Department of Paediatrics, Paediatric Gastroenterology and Hepatology Unit, Cliniques universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
• ³ Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherches Expérimentales et Cliniques, Université catholique de Louvain, Brussels, Belgium.
• ⁴ Genetics of Autoimmune Diseases and Cancer, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
• ⁵ Department of Pediatric Hematology and Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.